By Tom Winnifrith | Thursday 26 January 2017
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Apparently some folks think that Cloudtag (CTAG) is just a bad company not a fraud. I explain to such folks the difference between a fact and an opinion (Latin scholars are aware of this already) and why exactly that makes this company a 100% fraud. Its shares are now just 4.75p to sell but the target remains 0p as it is a fraud. Then it is on to the importance of NEDS and what they are there for ref Advanced Oncotherapy (AVO). Then I move to Ashley House (ASH) and a bit of macroeconomics, to Grand Group (GIPO) and onto Galantas Gold (GAL)
Already a subscriber? Click here to sign in
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Search ShareProphets |
Stock market news |
Recent Comments |
Site by Everywhen